Amicus Therapeutics Email Format

Amicus Therapeutics uses the firstinitiallast format, so Jane Smith would be jsmith@amicusrx.com.

Amicus Therapeutics markets Galafold (migalastat) for Fabry disease and the two-component therapy Pombiliti plus Opfolda (cipaglucosidase alfa-atga with miglustat) for late-onset Pompe disease, with both treatments approved across multiple countries including the U.S., EU, U.K., and Japan.

BioMarin Pharmaceutical completed its acquisition of Amicus Therapeutics in April 2026 for approximately $4.8 billion in an all-cash deal, adding Galafold and the Pombiliti plus Opfolda regimen to BioMarin's commercial rare disease portfolio.

Bradley Campbell serves as President and Chief Executive Officer of Amicus Therapeutics, based out of the company's headquarters in Princeton, NJ. He testified before the U.S. Senate Special Committee in support of Rare Disease Week in 2026.

Yes, Clay can help you build and enrich a contact list for Amicus Therapeutics by verifying email addresses using the firstinitiallast@amicusrx.com format and surfacing specific employees by role, team, or seniority across the company's roughly 625-person workforce.